Addex Therapeutics News

H.C. Wainwright Maintains Addex Therapeutics(ADXN.US) With Buy Rating, Maintains Target Price $30

Futu NewsOct 2 18:31

Buy Rating Affirmed for Addex Therapeutics Amid Promising Clinical Developments and Strategic Neurosterix Spinout

TipRanksOct 2 18:28

Addex Therapeutics Analyst Ratings

BenzingaAug 28 18:52

HC Wainwright & Co. Reiterates Buy on Addex Therapeutics, Maintains $30 Price Target

BenzingaAug 28 18:52

H.C. Wainwright Maintains Addex Therapeutics(ADXN.US) With Buy Rating, Maintains Target Price $30

Futu NewsAug 28 18:32

Positive Outlook for Addex Therapeutics: Significant Collaboration Payments and Promising Pipeline Drive Buy Rating

TipRanksAug 28 18:23

Analysts' Top Healthcare Picks: Addex Therapeutics (ADXN), Avidity Biosciences (RNA)

TipRanksAug 28 18:23

Addex Therapeutics Price Target Announced at $30.00/Share by HC Wainwright & Co.

Dow JonesJul 31 19:55

Addex Therapeutics Analyst Ratings

BenzingaJul 31 19:47

H.C. Wainwright Upgrades Addex Therapeutics(ADXN.US) to Buy Rating, Announces Target Price $30

Futu NewsJul 31 19:31

HC Wainwright Upgrades Addex Therapeutics to Buy From Neutral, Price Target Is $30

MT NewswiresJul 31 18:41